Oxygen adherence monitor for COPD patients
Part of Lungs & breathing clinical trials.
This study tests a device that tracks how often and how correctly you use your home oxygen. It aims to help you and your doctor see if you're getting the right amount of oxygen and to improve your breathing and quality of life.
Summary written for real people, not researchers, by Clin2.
Who can take part
- You have a COPD diagnosis from your doctor.
- Your doctor has prescribed oxygen for use at home through a nasal cannula or mask.
- You use oxygen continuously (all the time) at home, not just at certain times.
- You haven't been hospitalized or had a COPD flare-up in the past 6 weeks.
- Your breathing test (spirometry) shows that your FEV1/FVC ratio is less than 0.80, and your FEV1 is more than 25% of the predicted value.
- You are able to understand simple instructions and are currently in a stable health state.
Quick eligibility check
Answer a few plain-language questions, based on this study's own requirements, to get a preliminary sense of fit.
Similar studies
Other trials that look related to this one.
This trial tests a smart oxygen system that automatically adjusts oxygen levels for people with COPD who are in the hospital using a nasal high-flow device. It may help keep your oxygen levels stable without needing constant adjustments.
This study tests if monitoring your vital signs remotely (like oxygen levels and heart rate) can help improve care for people who need long-term oxygen therapy due to COPD or ILD. It may help you feel more supported at home.
This study tests a wearable device that listens to your breathing at home. It may help detect early signs of a COPD flare-up so you can get care sooner. You can join if you have moderate to severe COPD and recently left the hospital for a flare-up.
This study tests whether a home high-flow nasal breathing device (myAirvo 3) helps people with COPD who recently needed hospital care for a flare-up. You would use the device at home and track symptoms, oxygen levels, and heart rate daily to see how well it works.
This study tests a new device called MobiO2 that may help keep oxygen levels steady while you walk or exercise. If you usually need oxygen during activity, this could help you stay active more comfortably.
This study tests a device called MoblO2 to help people with COPD or interstitial lung disease keep their oxygen levels up during activity. If you normally use oxygen when you walk or exert yourself, this might help you stay active more safely.
Hear when a new COPD trial opens
We’ll email you when one opens — at most once a week, no account needed, unsubscribe anytime.